<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AID</journal-id><journal-title-group><journal-title>Advances in Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-2648</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aid.2023.132014</article-id><article-id pub-id-type="publisher-id">AID-124785</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Cytotoxic Lesions of the Corpus Callosum (CLOCCs) Associated with SARS-CoV-2 Infection in West Africa (C&#244;te d’Ivoire)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ismaila</surname><given-names>Diakité</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kotchi</surname><given-names>Elisée Bony</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hiénaya</surname><given-names>Armel Karidioula</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Any</surname><given-names>Gnazegbo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Muriel</surname><given-names>Tchwa Amon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kouame</surname><given-names>Léonard Kouassi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Idrissa</surname><given-names>Garba</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anhum</surname><given-names>Nicaise Konan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ange</surname><given-names>Eric Kouame Assouan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Radiology, Training and Research Unit for Medical Sciences, Felix Houphouet Boigny University, Abidjan, C&amp;amp;#244;te d’Ivoire</addr-line></aff><aff id="aff2"><addr-line>Department of Neurology, Training and Research Unit for Medical Sciences, Alassane Ouattara University Bouake, Bouake, C&amp;amp;#244;te d’Ivoire</addr-line></aff><aff id="aff1"><addr-line>Department of Neurology, Training and Research Unit for Medical Sciences, Felix Houphouet Boigny University, Abidjan, C&amp;amp;#244;te d’Ivoire</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>04</month><year>2023</year></pub-date><volume>13</volume><issue>02</issue><fpage>132</fpage><lpage>136</lpage><history><date date-type="received"><day>10,</day>	<month>January</month>	<year>2023</year></date><date date-type="rev-recd"><day>6,</day>	<month>May</month>	<year>2023</year>	</date><date date-type="accepted"><day>9,</day>	<month>May</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Cytotoxic lesions of the corpus callosum (CLOCCs) represent a collection of disparate conditions that can cause a signal change in the corpus callosum, usually involving the splenium. CLOCCs is present in a variety of disorders, such as cerebral infarction, bleeding, multiple sclerosis, acute disseminated encephalomyelitis, glioblastoma, lymphoma, metabolic diseases, and infections. Since 2020, World Health Organization (W.H.O) defined Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, as a pandemic. Numerous CLOCCs cases have been reported in adults in particular in Japan, in China, and recently in children in Turkey associated with SARS-CoV-2. We report the first case of CLOCCs diagnosed in West Africa (C
  &amp;#244;te d’Ivoire) in an adult associated with SARS-CoV-2. 
  Case Report: A 60 year-old-woman with a medical history of high blood pressure and diabetes, presented to the emergency department with confusion without fever. Neurological examination was normal apart from temporospatial disorientation. Brain magnetic resonance imaging (MRI) showed abnormal signals in the splenium of the corpus callosum (SCC). Forty-eight hours (48 h) after admission, the patient experienced a fever (temperature: 385
  &amp;#730;C), several episodes of hypoglycemia (capillary blood glycemia levels below 0.5 g/l) and a dry cough. Lung CT imaging showed typical features with ground-glass opacities. Oropharyngeal swab was positive for SARS-CoV-2 on reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay. The clinical course was favorable. One month after disease onset, a follow-up Brain MRI showed considerable regression of SCC abnormal signal. The multiple episodes of hypoglycemia and SARS-COV 2 infection were incriminated as the causal factors. 
  Conclusion: The improvement of the technical platform in our context of work gives us the possibility to identify the etiological factors of this rare clinico-radiological entity.
 
</p></abstract><kwd-group><kwd>Africa South of the Sahara</kwd><kwd> COVID-19</kwd><kwd> Corpus Callosum</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cytotoxic lesions of the corpus callosum (CLOCCs) represent a collection of conditions that can cause a signal change in the corpus callosum, usually involving the splenium. This term has been proposed recently as a more precise description of the phenomenon which has previously been known by a variety of terms including transient lesions of the splenium of the corpus callosum (SCC), mild encephalitis/encephalopathy with a reversible isolated SCC lesion (MERS), reversible splenial lesions syndrome (RESLES). CLOCCs is present in a variety of disorders, such as cerebral infarction, bleeding, multiple sclerosis, acute disseminated encephalomyelitis, glioblastoma, lymphoma, metabolic diseases, and infections [<xref ref-type="bibr" rid="scirp.124785-ref1">1</xref>] . Since 2020, World Health Organization (W.H.O) defined Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, as a pandemic. Numerous CLOCCs cases have been reported in adults in particular in Japan [<xref ref-type="bibr" rid="scirp.124785-ref1">1</xref>] , in China [<xref ref-type="bibr" rid="scirp.124785-ref2">2</xref>] , and recently in children in Turkey associated with SARS-CoV-2 [<xref ref-type="bibr" rid="scirp.124785-ref3">3</xref>] . We report the first case of CLOCCs diagnosed in West Africa (C&#244;te d’Ivoire) associated with SARS-CoV-2.</p></sec><sec id="s2"><title>2. Case Report</title><p>On June 01, 2021, a 60 year-old-woman with a medical history of high blood pressure and diabetes, presented with a confusion without fever. On arrival, her blood pressure, temperature and oxygen saturation were normal. Neurological examination was normal apart from temporospatial disorientation. The initial laboratory tests including the complete blood count (CBC), complete blood ionogram, glycemia, thyroid hormone and heart enzyme tests were normal. Computed tomographic (CT) imaging of the brain was normal. Brain magnetic resonance imaging (MRI) performed 12 hours after the onset of confusion showed a focal hyperintense signal in the SCC on diffusion weighted images (DWI) and a low ADC value. T2-fluid-attenuated inversion recovery (FLAIR) and the TOF were normal (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Cerebrospinal fluid (CSF) examination was normal (protein level, cytology, bacteriological examination). Forty-eight hours (48 h) after admission, the patient experienced a fever, several episodes of hypoglycemia and a dry cough. We noted the existence of a cough a few days before the onset of confusion and the D-dimer performed was high. The possibility of a viral infection of the SARS-COV-2 type was evoked given the pandemic context. Lung CT imaging showed typical features with ground-glass opacities (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Oropharyngeal swab was positive for SARS-CoV-2 and the patient was managed in a Covid treatment unit. She received symptomatic treatment: oxygen therapy, anticoagulants, glycemia management and antibiotics against bronchial superinfections. The clinical course was favorable, marked by the disappearance of the confusional syndrome and the negativity of the PCR test two weeks after his admission to the Covid treatment unit. The patient was discharged home. One month after disease onset, a follow-up Brain MRI showed considerable regression of SCC abnormal signal (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s3"><title>3. Discussion</title><p>We, herein, described the first case of CLOCCs associated with SARS-COV-2 infection in West Africa (C&#244;te d’Ivoire), presenting as a sudden onset confusional syndrome, after the two cases reported in a pediatric population by Gonca Bektas et al. [<xref ref-type="bibr" rid="scirp.124785-ref3">3</xref>] and the cases reported respectively by Hayashi et al. [<xref ref-type="bibr" rid="scirp.124785-ref4">4</xref>] and El Aoud [<xref ref-type="bibr" rid="scirp.124785-ref5">5</xref>] . CLOCCs is a rare clinico-radiological entity with numerous underlying etiologies identified. These lesions appear to result from a stereotyped cascade of cytokines and stimulated cells (macrophages, monocytes, T-cells, astrocytes) with a massive increase in glutamate in extracellular fluid, an influx of water into both astrocytes and neurons (cytotoxic edema) [<xref ref-type="bibr" rid="scirp.124785-ref2">2</xref>] . The reason why the splenium of corpus callosum is preferentially affected is the presence of a high density of oligodendrocytes expressing large numbers of glutamate affected receptors [<xref ref-type="bibr" rid="scirp.124785-ref2">2</xref>] . Various clinical presentations of CLOCCs have been reported, including agitation, disorientation, disturbed behavior or consciousness, comicality, and even transient ischemic attack [<xref ref-type="bibr" rid="scirp.124785-ref5">5</xref>] . Our patient presented with a sudden episode of disturbed consciousness, which initially suggested either a metabolic or vascular process, considering the history and the sudden onset of the disorder. The initial metabolic tests and the brain CT imaging were normal, which led to the performance of a MRI 12 hours after the onset of the disorders. Brain MRI showed a lesion of the SCC on DWI with a decrease in the ADC coefficient and normal FLAIR sequence. On the other side, Wen xu et al. [<xref ref-type="bibr" rid="scirp.124785-ref6">6</xref>] reported, in patients with CLOCCs, FLAIR hyper signal with DWI signal abnormalities and decreased ADC, for brain MRIs performed during a mean time of 5.36 &#177; 3.45 days after onset. Nevertheless, the normal FLAIR sequence, 12 hours after the onset, eliminates and ischemic stroke. Several etiological processes of CLOCCs have been reported in the literature, including antiepileptic treatments such as carbamazepine, phenytoin, vigabatrin, valproate, oxcarbazepine, levetiracetam, metabolic disorders such as hyponatremia [<xref ref-type="bibr" rid="scirp.124785-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.124785-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.124785-ref9">9</xref>] , hypoglycemia [<xref ref-type="bibr" rid="scirp.124785-ref10">10</xref>] , and infections, especially viral infections, with SARS-COV-2 [<xref ref-type="bibr" rid="scirp.124785-ref4">4</xref>] .</p></sec><sec id="s4"><title>4. Conclusion</title><p>CLOCCs is a rare clinico-radiological entity related to several causes including viral infections. The improvement of the technical platform in our context of work gives us the possibility to identify its etiological factors. The association of multiple episodes of hypoglycemia and covid 19 infection was the etiological factor highlighted.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Diakit&#233;, I., Bony, K.E., Karidioula, H.A., Gnazegbo, A., Amon, M.T., Kouassi, K.L., Garba, I., Konan, A.N. and Assouan, A.E.K. (2023) Cytotoxic Lesions of the Corpus Callosum (CLOCCs) Associated with SARS-CoV-2 Infection in West Africa (C&#244;te d’Ivoire). Advances in Infectious Diseases, 13, 132-136. https://doi.org/10.4236/aid.2023.132014</p></sec></body><back><ref-list><title>References</title><ref id="scirp.124785-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Lu, P.L., Hodes, J.F., Zheng, X. and Hu, X.Y. (2020) Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations. Internal Medicine, 59, 2471-2480. https://doi.org/10.2169/internalmedicine.4516-20</mixed-citation></ref><ref id="scirp.124785-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Starkey, J., Kobayashi, N., Numaguchi, Y. and Moritani, T. (2017) Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations. Radio Graphics, 37, 562-576. https://doi.org/10.1148/rg.2017160085</mixed-citation></ref><ref id="scirp.124785-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bektas, G., Ak&amp;#231;ay, N., Boydag, K. and Sevketoglu, E. (2021) Reversible Splenial Lesion Syndrome Associated with SARS-CoV-2 Infection in Two Children. Brain and Development, 43, 230-233. https://doi.org/10.1016/j.braindev.2020.10.002</mixed-citation></ref><ref id="scirp.124785-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Hayashi, M., Sahashi, Y., Baba, Y., Okura, H. and Shimohata, T. (2020) COVID-19-Associated Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion. Journal of the Neurological Sciences, 415, 116941. https://doi.org/10.1016/j.jns.2020.116941</mixed-citation></ref><ref id="scirp.124785-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Aoud, E.S., et al. (2020) A First Case of Mild Encephalitis with Reversible Splenial Lesion (MERS) as a Presenting Feature of SARS-CoV-2. Revue neurologique, 177, 1045. https://doi.org/10.1016/j.neurol.2021.09.002</mixed-citation></ref><ref id="scirp.124785-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Xu, W., Zhou, Y., Jiang, Y., Zhang, L. and Tang, Q.Q. (2019) Clinical and Magnetic Resonance Imaging Features of Reversible Splenial Lesion Syndrome in Adults: A Small Case Series. European Neurology, 82, 86-92. https://doi.org/10.1159/000505019</mixed-citation></ref><ref id="scirp.124785-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Tseng, Y.L., Huang, C.R., Lin, C.H., et al. (2014) Risk Factors of Hyperammonemia in Patients with Epilepsy under Valproic Acid Therapy. Medicine, 93, e66. https://doi.org/10.1097/MD.0000000000000066</mixed-citation></ref><ref id="scirp.124785-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Mori, H., Maeda, M., Takanashi, J., et al. (2012) Reversible Splenial Lesion in the Corpus Callosum Following Rapid Withdrawal of Carbamazepine After Neurosurgical Decompression for Trigeminal Neuralgia. Journal of Clinical Neuroscience, 19, 1182-1184. https://doi.org/10.1016/j.jocn.2011.09.017</mixed-citation></ref><ref id="scirp.124785-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Achalia, R. and Andrade, C. (2014) Reversible Abnormality of the Splenium in a Bipolar Patient with Neuroleptic Malignant Syndrome. Bipolar Disorders, 16, 773-775. https://doi.org/10.1111/bdi.12157</mixed-citation></ref><ref id="scirp.124785-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, S., Ma, Y. and Feng, J. (2015) Clinicoradiological Spectrum of Reversible Splenial Lesion Syndrome (RESLES) in Adults: A Retrospective Study of a Rare Entity. Medicine, 94, e512. https://doi.org/10.1097/MD.0000000000000512</mixed-citation></ref></ref-list></back></article>